Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis

被引:15
|
作者
Cho, Hyun Jin [1 ,2 ]
Lim, Yun-Ji [2 ,3 ]
Kim, Jhingook [4 ]
Koh, Won-Jung [5 ]
Song, Chang-Hwa [2 ,3 ]
Kang, Min-Woong [1 ,2 ]
机构
[1] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, 282 Munhwa Ro, Daejeon 35015, South Korea
[2] Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Daejeon, South Korea
[3] Chungnam Natl Univ, Coll Med, Dept Microbiol, 266 Munhwa Ro, Daejeon 35015, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea
关键词
Tuberculosis; Macrophages; Macrophage polarization; Multidrug-resistant; MYCOBACTERIUM-TUBERCULOSIS; ALTERNATIVE ACTIVATION; INFLAMMATION; CYTOKINES;
D O I
10.1186/s12879-020-4802-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Macrophages play a key role in the infection process, and alternatively activated macrophages (M2 polarization) play important roles in persistent infection via the immune escape of pathogens. This suggests that immune escape of pathogens from host immunity is an important factor to consider in treatment failure and multidrug-resistant tuberculosis (MDR-TB)/extensively drug-resistant tuberculosis (XDR-TB). In this study, we investigated the association between macrophage polarization and MDR-TB/XDR-TB and the association between macrophage polarization and the anti-TB drugs used. Methods iNOS and arginase-1, a surface marker of polarized macrophages, were quantified by immunohistochemical staining and imaging analysis of lung tissues of patients who underwent surgical treatment for pulmonary TB. Drug susceptibility/resistance and the type and timing of anti-tuberculosis drugs used were investigated. Results The M2-like polarization rate and the ratio of the M2-like polarization rate to the M1-like polarization rate were significantly higher in the MDR-TB/XDR-TB group than in the DS-TB group. The association between a high M2-like polarization rate and MDR-TB/XDR-TB was more pronounced in patients with a low M1-like polarization rate. Younger age and a higher M2-like polarization rate were independent associated factors for MDR-TB/XDR-TB. The M2-like polarization rate was significantly higher in patients who received anti-TB drugs containing pyrazinamide continuously for 4 or 6 weeks than in those who received anti-TB drugs not containing pyrazinamide. Conclusions The M2-like polarization of macrophages is associated with MDR-TB/XDR-TB and anti-TB drug regimens including pyrazinamide or a combination of pyrazinamide, prothionamide and cycloserine.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan
    Chiang, CY
    Yu, MC
    Bai, KJ
    Suo, J
    Lin, TP
    Lee, YC
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (03) : 272 - 277
  • [32] A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis
    Naidoo, Anushka
    Naidoo, Kogieleum
    McIlleron, Helen
    Essack, Sabiha
    Padayatchi, Nesri
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11) : 1369 - 1386
  • [33] Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
    Tabarsi, Payam
    Yadegarinia, Davood
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (01):
  • [34] Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis
    Gonzaloa, Ximena
    Casali, Nicola
    Broda, Agnieszka
    Pardieu, Claire
    Drobniewski, Francis
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (04) : 406 - 412
  • [35] Development of Extensively Drug-resistant Tuberculosis during Multidrug-resistant Tuberculosis Treatment
    Shin, Sonya S.
    Keshavjee, Salmaan
    Gelmanova, Irina Y.
    Atwood, Sidney
    Franke, Molly F.
    Mishustin, Sergey P.
    Strelis, Aivar K.
    Andreev, Yevgeny G.
    Pasechnikov, Alexander D.
    Barnashov, Alexander
    Tonkel, Tamara P.
    Cohen, Ted
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (03) : 426 - 432
  • [36] Prevalence of Multidrug-Resistant Tuberculosis at a Regional Drug-Resistant Tuberculosis Center of Maharashtra
    Kulkarni, Gauri Suhas
    Palwe, Supriya Dhakne
    Patil, Nilesh P.
    Telkhade, Abhijit J.
    Kadukar, Jui
    INDIAN JOURNAL OF RESPIRATORY CARE, 2020, 9 (01) : 30 - 34
  • [37] The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis
    Jo, Kyung-Wook
    Ji, Wonjun
    Hong, Yoonki
    Lee, Sang-Do
    Kim, Woo Sung
    Kim, Dong Soon
    Shim, Tae Sun
    RESPIRATORY MEDICINE, 2013, 107 (02) : 292 - 297
  • [38] Comparing Risk Factors for Primary Multidrug-Resistant Tuberculosis and Primary Drug-Susceptible Tuberculosis in Jiangsu Province, China: A Matched-Pairs Case-Control Study
    Li, Xin-Xu
    Lu, Wei
    Zu, Rong-Qiang
    Zhu, Li-Mei
    Yang, Hai-Tao
    Chen, Cheng
    Shen, Tao
    Zeng, Guang
    Jiang, Shi-Wen
    Zhang, Hui
    Wang, Li-Xia
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 92 (02) : 280 - 285
  • [39] DELAWANID FOR THE TREATMENT OF PULMONARY MULTIDRUG-RESISTANT TUBERCULOSIS
    Thakare, R.
    Soni, I.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2015, 51 (02) : 117 - 123
  • [40] Adverse drug reactions in multidrug-resistant tuberculosis
    Palmero, Domingo
    Cruz, Victor
    Museli, Tomas
    Pavlovsky, Hernan
    Fernandez, Juan
    Waisman, Jaime
    MEDICINA-BUENOS AIRES, 2010, 70 (05) : 427 - 433